Table 2.
Characteristics | 1990 | 2017 | 1990–2017 | ||
---|---|---|---|---|---|
Incident cases | ASIR per 100,000 | Incident cases | ASIR per 100,000 | EAPC(%)a | |
No. × 103 (95% UI) | No.(95% UI) | No. × 103 (95% UI) | No.(95% UI) | No.(95% CI) | |
Overall | 11,303 (10582–12,102) | 234 (219–249) | 22,936 (21083–25,041) | 285 (262–310) | 0.87 (0.79–0.96) |
Sex | |||||
Male | 5791 (5407–6214) | 240 (225–256) | 11,770 (10839–12,850) | 295 (273–321) | 0.89 (0.81–0.99) |
Female | 5512 (5162–5886) | 227 (213–243) | 11,166 (10244–12,217) | 274 (252–299) | 0.85 (0.77–0.94) |
Tape | |||||
Diabetes mellitus type 1 | 291 (263–323) | 5 (5–6) | 400 (362–442) | 5 (5–6) | 0.34 (0.30–0.39) |
Diabetes mellitus type 2 | 11,013 (10283–11,811) | 229 (214–244) | 22,535 (20694–24,627) | 279 (257–304) | 0.89 (0.80–0.97) |
Socio-demographic index | |||||
Low | 1102 (1019–1195) | 227 (209–245) | 2796 (2560–3054) | 284 (259–311) | 0.79 (0.71–0.88) |
Low-middle | 1901 (1759–2056) | 234 (217–253) | 4618 (4228–5032) | 304 (278–332) | 0.99 (0.92–1.07) |
Middle | 3049 (2834–3299) | 225 (209–242) | 6615 (6062–7248) | 286 (262–311) | 0.94 (0.85–1.02) |
Middle-high | 2544 (2365–2743) | 234 (218–251) | 4331 (3960–4766) | 260 (239–284) | 0.63 (0.48–0.78) |
High | 2661 (2511–2814) | 234 (221–247) | 4500 (4146–4910) | 286 (265–310) | 1.05 (0.92–1.17) |
Region | |||||
Asia Pacific–high income | 443 (411–479) | 221 (206–237) | 611 (549–679) | 230 (209–254) | 0.29 (0.10–0.48) |
Central Asia | 181 (169–195) | 310 (288–332) | 350 (320–387) | 376 (345–413) | 0.81 (0.73–0.89) |
East Asia | 2262 (2067–2479) | 180 (165–198) | 3573 (3244–3984 | 202 (185–222) | 0.82 (0.49–1.14) |
South Asia | 1824 (1677–1989) | 212 (195–230) | 4724 (4308–5182) | 286 (260–313) | 1.13 (0.97–1.29) |
Southeast Asia | 1090 (1014–1177) | 285 (265–306) | 2636 (2411–2889) | 382 (350–417) | 1.03 (0.94–1.13) |
Australasia | 50 (46–54) | 220 (204–236) | 79 (71–87) | 209 (190–229) | −0.05(−0.17–0.07) |
Caribbean | 96 (91–102) | 306 (290–323) | 168 (155–183) | 340 (314–369) | 0.30 (0.27–0.33) |
Central Europe | 362 (339–389) | 256 (240–273) | 472 (428–516) | 305 (280–333) | 0.68 (0.63–0.72) |
Eastern Europe | 614 (565–662) | 233 (215–251) | 700 (630–776) | 248 (226–273) | 0.25 (0.21–0.29) |
Western Europe | 1174 (1093–1243) | 236 (221–250) | 1862 (1698–2055) | 298 (273–326) | 0.82 (0.78–0.86) |
Andean Latin America | 59 (55–62) | 202 (190–215) | 147 (135–160) | 250 (230–273) | 0.81 (0.77–0.84) |
Central Latin America | 434 (408–463) | 341 (321–362) | 978 (902–1064) | 380 (351–413) | 0.19 (0.08–0.30) |
Southern Latin America | 142 (132–151) | 295 (274–314) | 244 (221–267) | 330 (301–361) | 0.47 (0.43–0.52) |
Tropical Latin America | 272 (254–291) | 217 (203–233) | 494 (452–544) | 206 (188–226) | −0.30(−0.40– −0.19) |
North Africa and Middle East | 733 (680–794) | 291 (269–315) | 2164 (1980–2370) | 384 (351–420) | 1.09 (1.03–1.15) |
North America high-income | 722 (676–772) | 235 (219–251) | 1518 (1402–1639) | 317 (295–340) | 1.98 (1.64–2.31) |
Oceania | 28 (26–30) | 536 (501–579) | 74 (68–81) | 655 (604–712) | 0.68 (0.56–0.80) |
Central Sub-Saharan Africa | 139 (128–151) | 381 (352–413) | 384 (353–423) | 452 (413–494) | 0.64 (0.60–0.68) |
Eastern Sub-Saharan Africa | 314 (291–339) | 271 (251–291) | 726 (664–797) | 290 (264–317) | 0.25 (0.23–0.27) |
Southern Sub-Saharan Africa | 127 (118–138) | 329 (305–356) | 311 (285–340) | 453 (416–495) | 1.33 (1.18–1.47) |
Western Sub-Saharan Africa | 237 (219–258) | 184 (169–200) | 721 (661–795) | 251 (227–274) | 1.14 (1.10–1.19) |
ASIR age-standardized incidence rate, CI confidence interval, EAPC estimated annual percentage change, UI uncertainty interval
aThe ASIR was deemed to be in an increasing trend if the EAPC and the lower boundary of its 95% CI were both > 0%;the ASIR was in a decreasing trend if the EAPC estimation and the upper boundary of its 95% CI were both < 0%; otherwise, the ASIR was deemed to be uncertain over time